Popular

Case Studies

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 The Wall Street Analyzer Comments Off on Acutus Medical (NASDAQ: AFIB)

Acutus Medical, Inc’s (NASDAQ: AFIB) CEO David Roman recently spoke with Wall Street Analyzer to provide an overview of the company, discuss recent news, and go over key goals for the next 6-8 months. The company is focused on the treatment of atrial fibrillation and other cardiac arrhythmias and has a novel mapping system that enables physicians to visualize disease on a patient by patient basis and therefore has a higher success rate than current standard of care procedures. Mr. Roman went over AFIB’s recent Q3 results that included an over 50% increase in their international procedures and a 17% year to year growth in overall procedures. Perhaps the biggest announcement was the company’s deal with Medtronic for sale of their access portfolio, referred to as Left Heart Access (LHA), and consists of uncapped revenue based earn-outs for four years after the official launch. Acutus Medical produced $17.3 million in revenue in 2021. […]

News Feed

Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash

November 15, 2022 The Wall Street Analyzer Comments Off on Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash

ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for […]

News Feed

SCOTTIE RESOURCES EXTENDS STRIKE OF BLUEBERRY CONTACT ZONE TO 1.45 KILOMETERS AND REPORTS INTERCEPT OF 4.24 G/T GOLD OVER 16.95 METRES

November 9, 2022 The Wall Street Analyzer Comments Off on SCOTTIE RESOURCES EXTENDS STRIKE OF BLUEBERRY CONTACT ZONE TO 1.45 KILOMETERS AND REPORTS INTERCEPT OF 4.24 G/T GOLD OVER 16.95 METRES

VANCOUVER, BC, Nov. 8, 2022 /CNW/ – Scottie Resources Corp. (“Scottie” or the “Company“) (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is pleased to report new assays on its Blueberry Contact Zone including an intercept of 20.3 g/t gold […]

News Feed

SCOTTIE RESOURCES EXTENDS DEPTH OF BLUEBERRY CONTACT ZONE TO 360 METRES WITH INTERCEPT OF 7.07 G/T GOLD OVER 24.55 METRES

September 14, 2022 The Wall Street Analyzer Comments Off on SCOTTIE RESOURCES EXTENDS DEPTH OF BLUEBERRY CONTACT ZONE TO 360 METRES WITH INTERCEPT OF 7.07 G/T GOLD OVER 24.55 METRES

VANCOUVER, BC, Sept. 13, 2022 /CNW/ – Scottie Resources Corp. (“Scottie” or the “Company“) (TSXV: SCOT) (OTC-QB: SCTSF) (FSE: SR8) is pleased to report assays on its Blueberry Contact Zone including 7.07 g/t gold over 24.55 metres which extends […]

News Feed

Canaquest Launches Mentanine ® (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

September 9, 2022 The Wall Street Analyzer Comments Off on Canaquest Launches Mentanine ® (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

USERS REPORT INCREASED MENTAL CLARITY,BETTER SLEEP, MORE ENERGY, AND LESS BRAIN FOG AND JOINT STIFFNESS […]

News Feed

Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans

May 17, 2022 The Wall Street Analyzer Comments Off on Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans

ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce the interview with […]